Old Web
English
Sign In
Acemap
>
Paper
>
DaraRD in systemic AL amyloidosis: high efficacy, relevant toxicity and main adverse effect of gain 1q21.
DaraRD in systemic AL amyloidosis: high efficacy, relevant toxicity and main adverse effect of gain 1q21.
2021
Christoph Kimmich
Tobias Terzer
Axel Benner
Timon Hansen
Alexander Carpinteiro
Tobias Dittrich
Kaya Veelken
Anna Jauch
Stefanie Huhn
Marco Basset
Hartmut Goldschmidt
Carsten Müller-Tidow
Stefan Schönland
Ute Hegenbart
Keywords:
AL amyloidosis
Toxicity
Adverse effect
Bioinformatics
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
7
References
2
Citations
NaN
KQI
[]
map